SingaporeTuberculosis profile
Population  2014 5.5 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.057 (0.048–0.068) 1 (0.87–1.2)
Mortality (HIV+TB only) 0.013 (<0.01–0.018) 0.24 (0.17–0.32)
Prevalence  (includes HIV+TB) 3.4 (1.4–6.2) 62 (26–113)
Incidence  (includes HIV+TB) 2.7 (2.4–3.1) 49 (43–56)
Incidence (HIV+TB only) 0.075 (0.065–0.086) 1.4 (1.2–1.6)
         
Case detection, all forms (%) 80 (71–92)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 1.1 (0.54–1.9) 1.3 (0.03–7.1)
MDR-TB cases among notified pulmonary
TB cases
19 (9–33) 2 (0–10)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 1 056   93
Pulmonary, clinically diagnosed 649   42
Extrapulmonary 313   18
       
Total new and relapse 2 171    
Previously treated, excluding relapses 0    
Total cases notified 2 171    
Among 2 171 new and relapse cases:
17 (<1%) cases aged under 15 years; male:female ratio: 1.8
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 1 217 (115%) 93 (61%) 1 310
Laboratory-confirmed RR-/MDR-TB cases     16
Patients started on MDR-TB treatment ***     16
TB/HIV 2014 Number (%)
TB patients with known HIV status 1 827 (84)
HIV-positive TB patients 50 (3)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (77) 2 142
Previously treated cases, excluding relapse, registered in 2013 (75) 8
HIV-positive TB cases, all types, registered in 2013 (86) 51
RR-/MDR-TB cases started on second-line treatment in 2012 (55) 22
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-06-30 Data: www.who.int/tb/data